Categories Earnings, Health Care

Moderna impresses on the financial side as well in Q2

Gets $400 million in customer deposits for the potential supply of its vaccine across the world

Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past analysts’ estimates. The company’s revenues during the second quarter came in at $66.3 million, more than double of what the street had anticipated.

Q2 net loss narrowed to 31 cents per share, compared to 41 cents per share a year ago. Analysts had quoted a net loss of 35 cents per share.   

Moderna shares rose 1.5% immediately following the announcement. MRNA stock is one of the top performers this year, rising 310% since January.

Moderna Inc earnings Q2.

Looking forward to listening to management/ analyst comments on Q2 results? Stay tuned here for Moderna Q2 2020 earnings call transcript

Moderna said it has received about $400 million in customer deposits for the potential supply of its Phase 3 Covid-19 vaccine mRNA-1273.

CEO Stéphane Bancel said, “As we pivot to a commercial-stage company, we recognize the need for responsible pricing in the face of the pandemic. We look forward to continuing our progress as we prepare for the Phase 3 readout and the expected subsequent filing of our BLA.”

Enrollment is ongoing for the Phase 3 COVE study.

Last month, the company had provided Phase 1 interim results, besides announcing the start of Phase 3 trials on July 27.  

[irp posts=”65979″]

____

Most Popular

Key takeaways from Kroger’s (KR) Q1 2025 earnings report

The Kroger Co. (NYSE: KR) recently reported mixed results for the first quarter of fiscal 2025, with earnings beating estimates and sales missing. The grocery giant’s stock rose following the

What to expect when McCormick & Company (MKC) reports Q2 2025 earnings results

Shares of McCormick & Company, Incorporated (NYSE: MKC) gained over 1% on Monday. The stock has dropped 7% over the past three months. The condiments maker is slated to report its second

Earnings Preview: Paychex (PAYX) looks set to end FY25 on a strong note

Paychex Inc. (NASDAQ: PAYX) has benefited from the stable labor market and resilient customers, despite inflationary pressures and the challenging economic environment. The company is leveraging its strong fundamentals and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top